pubmed-article:20452141 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20452141 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:20452141 | lifeskim:mentions | umls-concept:C0927232 | lld:lifeskim |
pubmed-article:20452141 | lifeskim:mentions | umls-concept:C0205851 | lld:lifeskim |
pubmed-article:20452141 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:20452141 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
pubmed-article:20452141 | lifeskim:mentions | umls-concept:C0033727 | lld:lifeskim |
pubmed-article:20452141 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:20452141 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:20452141 | pubmed:dateCreated | 2010-12-14 | lld:pubmed |
pubmed-article:20452141 | pubmed:abstractText | To report early clinical outcomes for children with central nervous system (CNS) germ cell tumors treated with protons; to compare dose distributions for intensity-modulated photon radiotherapy (IMRT), three-dimensional conformal proton radiation (3D-CPT), and intensity-modulated proton therapy with pencil beam scanning (IMPT) for whole-ventricular irradiation with and without an involved-field boost. | lld:pubmed |
pubmed-article:20452141 | pubmed:language | eng | lld:pubmed |
pubmed-article:20452141 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20452141 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20452141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20452141 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20452141 | pubmed:month | Jan | lld:pubmed |
pubmed-article:20452141 | pubmed:issn | 1879-355X | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:TarbellNancy... | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:AdamsJudithJ | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:YockTorunn... | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:EbbDavidD | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:TrofimovAlexe... | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:SafaiSairosS | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:FullertonBarb... | lld:pubmed |
pubmed-article:20452141 | pubmed:author | pubmed-author:MacDonaldShan... | lld:pubmed |
pubmed-article:20452141 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:20452141 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20452141 | pubmed:day | 1 | lld:pubmed |
pubmed-article:20452141 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:20452141 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20452141 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20452141 | pubmed:pagination | 121-9 | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:meshHeading | pubmed-meshheading:20452141... | lld:pubmed |
pubmed-article:20452141 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:20452141 | pubmed:articleTitle | Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. | lld:pubmed |
pubmed-article:20452141 | pubmed:affiliation | Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. smacdonald@partners.org | lld:pubmed |
pubmed-article:20452141 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20452141 | pubmed:publicationType | Comparative Study | lld:pubmed |